Page 22 - Third Rock News Today : Breaking News, Live Updates & Top Stories | Vimarsana

This story is available exclusively to Insider subscribers. Become an Insider and start reading now. The FDA approved BridgeBio's first drug, for a disease that affects 100 children in the US and Europe. BridgeBio mitigates risk with a "hub-and-spoke" model, with a central management team and subsidiaries. The model is gaining in popularity in biopharma and could reshape drug R&D, McKinsey & Co. says. It wasn't that long ago that the idea behind BridgeBio drew laughter from biotech and finance experts.  But these days, CEO Neil Kumar says he's taking calls...

Mar 2, 2021 Blood tests for biomarkers and the possibility of the first disease-modifying treatment on the horizon Recent Alzheimer’s disease research has poised the field for a watershed period in diagnosis and treatment, which may begin as early as this year. This shifting clinical landscape in Alzheimer’s research includes blood tests to identify possible biomarkers, the first FDA-approved tau PET ligand, and the possibility of the first disease-modifying therapy — the amyloid beta (Aβ)-targeted monoclonal antibody aducanumab — that may be approved by the FDA this year. Moreover, ...

Alcresta Therapeutics Announces Publication of NASPGHAN Position Paper Recommending RELiZORB® in Children with Chronic Pancreatitis News provided by Share this article Share this article NEWTON, Mass., Feb. 23, 2021 /PRNewswire/ -- Alcresta Therapeutics, Inc., a leading commercial-stage company focused on developing and commercializing novel enzyme-based products, today announced  publication of a position paper by the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) Pancreas Committee recommending the use of RELiZORB ® (immobilized lipase cartr...

Justin Roiland's 'Solar Opposites' Puts a New Spin on His "Constantly Escalating Absurdity" The 'Rick and Morty' co-creator on the "lighter and sillier" tone of his new show Published Feb 22, 2021 Cartoon watchers already know Justin Roiland as the co-creator and main voice behind Rick and Morty — and fans of that show's fast pace, irreverent tone and absurdist humour will find plenty more where that came from in his latest series, Solar Opposites (the second season of which comes to the new Disney+ hub Star on March 26). In fact, Roiland was worried about comparisons between the two sh...

Winner of the AIM-HI Accelerator Fund’s Inaugural Women’s Venture Competition Announced Share Article ROCKVILLE, Md. (PRWEB) February 22, 2021 Privo Technologies and its chief executive officer, Manijeh Goldberg, Ph.D., have been selected as the winner of the AIM-HI Accelerator Fund’s inaugural Women’s Venture Competition, a first of its kind program for female entrepreneurs starting oncology companies. Privo Technologies has developed a nano-engineered platform for redesigning the mechanism of action of potent cancer me...